Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT01083329 Completed - Obesity Clinical Trials

Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects

ANITA
Start date: January 2010
Phase: Phase 2
Study type: Interventional

Our working hypothesis postulates that lipolysis is a determinant of inflammation in adipose tissue (AT). Inhibition of lipolysis, e.g. using the oldest normolipidemic drug, nicotinic acid, has proved valuable to combat the metabolic syndrome. Our proposal will determine whether part of the beneficial effects of this antilipolytic compound is due to a diminution of AT inflammation. To this aim, the effect of nicotinic acid or placebo will be studied in male obese subjects with or without a training program which goal is to enhance lipolysis.

NCT ID: NCT01082588 Completed - Schizophrenia Clinical Trials

Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia

Start date: June 2010
Phase: Phase 4
Study type: Interventional

This study involves people with schizophrenia or schizoaffective disorder, who are currently taking antipsychotic medications. Some antipsychotic medications may cause an increase in cholesterol levels, which may lead to inflammation in the body. Inflammation poses a risk in developing heart disease, diabetes and problems with brain function. The purpose of this study is to see if pravastatin can: - Lower cholesterol - Decrease inflammation - Improve cognition in patients with schizophrenia

NCT ID: NCT01081392 Active, not recruiting - Inflammation Clinical Trials

Inflammatory Markers in Sputum After LPS Inhalation

Start date: January 2010
Phase: N/A
Study type: Interventional

The purpose of the study is to measure inflammatory biomarkers in sputum and peripheral blood in healthy volunteers after inhalation of single doses of LPS (20 mcg) administered as particles of different sizes.

NCT ID: NCT01078909 Completed - Inflammation Clinical Trials

Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation

Start date: October 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the lowest effective dose of EPA + DHA (300, 600, 900 and 1,800 mg/day delivered as fish oil supplements) that significantly attenuates the inflammatory response to in vivo and ex vivo endotoxin challenge as measured by the production over time of several inflammatory markers.

NCT ID: NCT01073982 Completed - Pain Clinical Trials

Efficacy of Tart Cherry Juice to Reduce Pain and Inflammation Among Patients With Inflammatory Osteoarthritis

Start date: February 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effects of tart cherry juice to reduce pain and inflammation among individuals with arthritis.

NCT ID: NCT01072903 Completed - Inflammation Clinical Trials

The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)

K23
Start date: January 2009
Phase: N/A
Study type: Observational

The research project addresses the following hypotheses (A) the normal balance of beneficial and detrimental commensal intestinal bacteria is deranged in IBS, with selective alterations in clinically defined patient subsets i.e., diarrhea predominant IBS (D-IBS) and post-infectious IBS (PI-IBS); (B) these changes in intestinal microflora are associated with sub-clinical mucosal inflammation and activation of the mucosal immune system; and (C) activation of the mucosal immune system leads to alterations in gastrointestinal (GI) functions (i.e., motility and sensation) and functional symptoms.

NCT ID: NCT01066637 Completed - Clinical trials for Patients With Post Orthotopic Heart Transplantation Status

iNOS With Positron Emission Tomography (PET) in Cellular Inflammation.

F-NOS
Start date: September 2009
Phase: Early Phase 1
Study type: Interventional

The primary purpose of this study is to measure the level of an enzyme in a patient's heart called inducible nitric oxide synthase(iNOS) using Positron Emission Tomography (PET) imaging with a radioactive tracer called 18F-NOS. These PET results will be compared to tissue results obtained during routine endomyocardial heart biopsy. The enzyme iNOS produces nitric oxide in inflammatory diseases such as acute heart transplant rejection, diabetes, Alzheimer's and cancer. Thus, PET with the radioactive tracer 18F-NOS may be a useful tool for detecting the early stages of these diseases. The safety of 18F-NOS during the study will also be assessed. All PET imaging will be performed with a CTI/Siemens Biograph 40 PET/CT scanner. Protocol was revised to add new imaging modality, Biograph mMR PET-MR scanner in order to investigate new hardware and software in order to optimize scanning procedures in order to refine image quality so that we can apply the findings to future standard clinical scans and research imaging studies. Ten additional status-post OHT patients who are scheduled for standard of care endomyocardial biopsy for allograft rejection surveillance will undergo PET/MR imaging with [18F](+/-)NOS.

NCT ID: NCT01060787 Completed - Inflammation Clinical Trials

Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

Start date: February 4, 2016
Phase:
Study type: Observational

Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants

NCT ID: NCT01060072 Completed - Pain Clinical Trials

Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery

Start date: February 2010
Phase: Phase 3
Study type: Interventional

This study is being conducted to compare the safety and efficacy of loteprednol etabonate to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.

NCT ID: NCT01058161 Completed - Inflammation Clinical Trials

High-Field MRI Characterization of Wrist and Hand Cartilage Abnormalities in Inflammatory and Chronic Rheumatisms

Start date: December 2009
Phase: N/A
Study type: Interventional

The present project aims at evaluating the diagnostic potential of high-field MRI (3 Teslas) for joint disease. At this field, given that isotropic image resolution of 400 microns can be obtained, one could expect an early detection of joint abnormalities. The additional aim of this project will be to develop a quantitative analyse of the corresponding high-resolution images.